Return to homepagePandemic Pact

ITAC (INSIGHT-13)

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-297

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    N/A

  • Research Location

    United Kingdom

  • Lead Research Institution

    MRC Clinical Trials Unit at UCL

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Clinical trials for disease management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of hyperimmune IVIG for the treatment of adult patients hospitalised with COVID-19